Toll Access
Cover_TOC_Masthead - ISSUE 1/2018
DOI: 10.21307/immunohematology-2018-001a
Publications
Immunohematology
Journal of Blood Group Serology and Molecular Genetics
American National Red Cross
Subject: Medical Laboratory Technology
ISSN: 0894-203X
eISSN: 1930-3955
FEATURED ARTICLES
Blood group discrepancy in Ah para-Bombay phenotype: a rare blood group variant and its clinical significance
SEARCH WITHIN CONTENT
Archive
Volume 37
(2021)
Volume 36
(2020)
Volume 35
(2019)
Volume 34
(2018)
Volume 33
(2017)
Volume 32
(2016)
Volume 31
(2015)
Volume 30
(2014)
Volume 29
(2013)
Volume 28
(2012)
Volume 27
(2011)
Volume 26
(2010)
Volume 25
(2009)
Volume 24
(2008)
Volume 23
(2007)
Volume 22
(2006)
Volume 21
(2005)
Volume 20
(2004)
Volume 19
(2003)
Volume 18
(2002)
Volume 17
(2001)
Volume 16
(2000)
Volume 15
(1999)
Volume 14
(1998)
Volume 13
(1997)
Volume 12
(1996)
Volume 11
(1995)
Volume 10
(1994)
Volume 9
(1993)
Volume 8
(1992)
Volume 7
(1991)
Volume 6
(1990)
Volume 5
(1989)
Volume 4
(1988)
Volume 3
(1987)
Trending Articles
VOLUME 34 , ISSUE 1 (March 2018) - List of articles
Toll Access
Warm autoadsorption using ZZAP
Farai M. Tsimba-Chitsva/ Amy Caballero/ Becky Svatora
DOI: 10.21307/immunohematology-2018-001
Toll Access
A brief overview of clinical significance of blood group antibodies
Manish J. Gandhi/ D. Michael Strong/ Barbee I. Whitaker/ Evangelia Petrisli
DOI: 10.21307/immunohematology-2018-002
Toll Access
Management of pregnancy sensitized with anti-Inb with monocyte monolayer assay and maternal blood donation
Raj Shree/ Kimberly K. Ma/ Lay See Er/ Meghan Delaney
DOI: 10.21307/immunohematology-2018-003
Toll Access
A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies
Sandra J. Nance
DOI: 10.21307/immunohematology-2018-004
Toll Access
Recovery of autologous sickle cells by hypotonic wash
Emily Wilson/ Kelly Kezeor/ Monica Crosby
DOI: 10.21307/immunohematology-2018-005
Toll Access
Letter to the Editor: The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor
Laura L.W. Cooling/ Michelle Herrst/ Sherri L. Hugan
DOI: 10.21307/immunohematology-2018-006
No Record Found..